Cargando…

How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study

BACKGROUND AND AIM: Chronic kidney disease (CKD) is frequent in type 2 diabetes mellitus (T2DM), and therapeutic management of diabetes is more challenging in patients with renal impairment (RI). The place of metformin is of particular interest since most scientific societies now recommend using hal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Penfornis, Alfred, Blicklé, Jean Frédéric, Fiquet, Béatrice, Quéré, Stéphane, Dejager, Sylvie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063863/ https://www.ncbi.nlm.nih.gov/pubmed/24966684 http://dx.doi.org/10.2147/VHRM.S60312

Ejemplares similares

Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study
por: Penfornis, Alfred, et al.
Publicado: (2015)

Physical activity in patients with type 2 diabetes and hypertension – insights into motivations and barriers from the MOBILE study
por: Duclos, Martine, et al.
Publicado: (2015)

Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study
por: Halimi, Serge, et al.
Publicado: (2013)

Blood pressure and proteinuria control remains a challenge in patients with type 2 diabetes mellitus and chronic kidney disease: experience from the prospective observational ALICE-PROTECT study
por: Halimi, Jean-Michel, et al.
Publicado: (2016)

Breaking Barriers to Effective Type 2 Diabetes Management: Findings from the use of the OPTIMA© Questionnaire in Clinical Practice
por: Grimaldi, André, et al.
Publicado: (2016)

OPADIA Study: Is a Patient Questionnaire Useful for Enhancing Physician-Patient Shared Decision Making on Physical Activity Micro-objectives in Diabetes?
por: Consoli, Silla M., et al.
Publicado: (2020)

Experience with Vildagliptin in Patients ≥75 Years with Type 2 Diabetes and Moderate or Severe Renal Impairment
por: Schweizer, Anja, et al.
Publicado: (2013)

Minimizing the risk of hypoglycemia with vildagliptin: Clinical experience, mechanistic basis, and importance in type 2 diabetes management
por: Dejager, Sylvie, et al.
Publicado: (2011)

Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan
por: Schweizer, Anja, et al.
Publicado: (2013)

Evidence to support the use of vildagliptin monotherapy in the treatment of type 2 diabetes mellitus
por: Dejager, Sylvie, et al.
Publicado: (2012)

The onset of acute Charcot neuroarthropathy during pregnancy in patients with type 1 diabetes
por: Dardari, Dured, et al.
Publicado: (2020)

Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA Study
por: Simon, Dominique, et al.
Publicado: (2014)

Magnitude of the Dawn Phenomenon and Its Impact on the Overall Glucose Exposure in Type 2 Diabetes: Is this of concern?
por: Monnier, Louis, et al.
Publicado: (2013)

Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice—EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing Study
por: Gautier, Jean-Francois, et al.
Publicado: (2015)

Medication Adherence in Type 2 Diabetes: The ENTRED Study 2007, a French Population-Based Study
por: Tiv, Michel, et al.
Publicado: (2012)

Effectiveness and Persistence of Liraglutide Treatment Among Patients with Type 2 Diabetes Treated in Primary Care and Specialist Settings: A Subgroup Analysis from the EVIDENCE Study, a Prospective, 2-Year Follow-up, Observational, Post-Marketing Study
por: Martinez, Luc, et al.
Publicado: (2017)

Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet
por: Halimi, Serge, et al.
Publicado: (2008)

The Effectiveness of an App (Insulia) in Recommending Basal Insulin Doses for French Patients With Type 2 Diabetes Mellitus: Longitudinal Observational Study
por: Nevoret, Camille, et al.
Publicado: (2023)

Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?
por: Evans, Marc, et al.
Publicado: (2015)

Evaluation of Iodine Supplementation in Pregnant Women with Gestational Diabetes: IODIAB Study
por: Dardari, Dured, et al.
Publicado: (2022)

Fracture of the Bone Inducing Its Necrosis as the End Point in the Evolution of Untreated Neuroarthropathy
por: Dardari, Dured, et al.
Publicado: (2021)

COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring
por: Salabelle, Claire, et al.
Publicado: (2021)

Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database
por: Detournay, Bruno, et al.
Publicado: (2015)

Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement
por: Giorgino, Francesco, et al.
Publicado: (2018)

Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis
por: Charbonnel, Bernard, et al.
Publicado: (2017)

Hospital stays and costs of telemedical monitoring versus standard follow-up for diabetic foot ulcer: an open-label randomised controlled study
por: Dardari, Dured, et al.
Publicado: (2023)

Curing Necrotic Angiodermatitis with an Intact Fish Skin Graft in a Patient Living with Diabetes
por: Dardari, Dured, et al.
Publicado: (2022)

Impact of Intensive Glycemic Treatment on Diabetes Complications—A Systematic Review
por: Poonoosamy, Juliana, et al.
Publicado: (2023)

Morphometrics as an Insight Into Processes Beyond Tooth Shape Variation in a Bank Vole Population
por: Ledevin, Ronan, et al.
Publicado: (2010)

Impact of Insulin Resistance, Body Mass Index, Disease Duration, and Duration of Metformin Use on the Efficacy of Vildagliptin
por: Schweizer, Anja, et al.
Publicado: (2012)

Post-healing follow-up study of patients in remission for diabetic foot ulcers Pied-REM study
por: Bouly, Marie, et al.
Publicado: (2022)

Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database
por: Emery, Corinne, et al.
Publicado: (2020)

Rapid glycemic regulation in poorly controlled patients living with diabetes, a new associated factor in the pathophysiology of Charcot’s acute neuroarthropathy
por: Dardari, Dured, et al.
Publicado: (2020)

New Insight into the Colonization Processes of Common Voles: Inferences from Molecular and Fossil Evidence
por: Tougard, Christelle, et al.
Publicado: (2008)

Providing the basis for a patient-centred and effective screening for cancer-related fatigue (MERLIN study): design of a longitudinal observational study
por: Blickle, Patricia, et al.
Publicado: (2023)

Grammaire progressive du français des affaires: avec 350 exercices : niveau intermédiaire
por: Penfornis, Jean-Luc
Publicado: (2014)

Français.com : méthode de français professionnel et des affaires : niveau débutant /
por: Penfornis, Jean-Luc
Publicado: (2011)

Français.com : méthode de français professionnel et des affaires : niveau intermédiaire /
por: Penfornis, Jean-Luc
Publicado: (2011)

Affaires.com : français professionnel : niveau avancé B2-C1 /
por: Penfornis, Jean-Luc
Publicado: (2017)

Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies
por: Schweizer, Anja, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5va1c4gab8v0mdibfe8ummbmhq